Ophthalmology · Dayton, OH
NPI
1578527461
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
617 Shroyer Road
Dayton, OH, 45419
Phone (937) 461-1111
Groups this clinician bills Medicare through
Medicare paid, 2024
$180K
4,147 services
Medicare patients, 2024
452
Average age 77
Drug cost, 2024
$604K
5,418 prescriptions
Company payments, 2025
$433
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephen P Schumann was code 66984 (cataract surgery), 1,914 times for 84 patients. In total Stephen P Schumann billed 4,147 services in 42 codes, and Medicare paid $180K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 66984 Cataract Surgery | Facility | 1,914 | 84 | $25.71 | $49K |
| 66991 Cataract Surgery | Facility | 412 | 27 | $45.58 | $19K |
| 92012 Ophthalmological E&M | Office | 263 | 191 | $57.18 | $15K |
| 92014 Ophthalmological E&M | Office | 212 | 203 | $76.57 | $16K |
| 92083 Vision, Hearing, and Speech Services | Office | 205 | 132 | $40.73 | $8,349 |
| 92136 Ultrasound - Nonspecific | Office | 186 | 127 | $28.05 | $5,216 |
| 92020 Ophthalmological E&M | Office | 163 | 108 | $19.29 | $3,145 |
| 92133 Computerized Ophthalmic Imaging | Office | 157 | 145 | $21.68 | $3,404 |
| 92134 Computerized Ophthalmic Imaging | Office | 126 | 103 | $25.81 | $3,251 |
| 99204 Office E&M - New | Office | 98 | 98 | $114.14 | $11K |
| 99214 Office E&M - Established | Office | 72 | 63 | $82.93 | $5,971 |
| 92025 Test - Miscellaneous | Office | 71 | 52 | $23.13 | $1,642 |
| 92004 Ophthalmological E&M | Office | 67 | 67 | $100.44 | $6,729 |
| 66821 Cataract Surgery | Office | 45 | 40 | $238.76 | $11K |
| 76514 Ultrasound - Nonspecific | Office | 44 | 44 | $7.59 | $334 |
By year: 2022 $206K for 4,828 services; 2023 $202K for 4,765 services; 2024 $180K for 4,147 services.
Medicare prescription drug claims, 2024
In 2024, the drug Stephen P Schumann prescribed most often to Medicare patients was Latanoprost, with 1,032 prescriptions and refills. In total Stephen P Schumann wrote 5,418 Medicare prescriptions that cost $604K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 1,032 | 2,192 | 278 | $7,387 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 630 | 1,449 | 182 | $9,897 |
| Brimonidine Tartrate Generic | 483 | 1,069 | 134 | $16K |
| Prednisolone Acetate Generic | 437 | 879 | 268 | $19K |
| Timolol Maleate Generic | 404 | 1,034 | 127 | $3,084 |
| Ofloxacin Generic | 303 | 385 | 256 | $4,794 |
| Lumigan Bimatoprost | 239 | 407 | 60 | $102K |
| Dorzolamide Hcl Generic | 188 | 398 | 54 | $3,017 |
| Rocklatan Netarsudil Mesylat/Latanoprost | 175 | 272 | 49 | $87K |
| Dorzolamide-Timolol Dorzolamide/Timolol/Pf | 155 | 250 | 36 | $20K |
| Rhopressa Netarsudil Mesylate | 126 | 184 | 46 | $52K |
| Fluorometholone Generic | 110 | 167 | 66 | $7,118 |
| Travoprost Generic | 97 | 192 | 26 | $15K |
| Alphagan P Brimonidine Tartrate | 81 | 118 | 16 | $22K |
| Tafluprost Tafluprost/Pf | 74 | 121 | 19 | $13K |
Brand drugs: 1,851 claims; generic drugs: 3,567 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stephen P Schumann $433 ($433 in general payments such as food, travel and fees) from 6 companies. The largest payer was Johnson & Johnson Surgical Vision, Inc. with $136.
| Company | Payments | Amount |
|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. JNJ | 2 | $136 |
| Glaukos Corporation GKOS | 1 | $120 |
| Alcon Vision LLC ALC | 3 | $84.65 |
| Harrow Eye, LLC | 1 | $33 |
| Sight Sciences, Inc. SGHT | 1 | $30.67 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 1 | $29.18 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.